$SAGE is an interesting stock here, has pending catalysts for mid 2023, which fit the expectations from the Time@Mode technical pattern at hand here. Consider the volatility of these biotech names when entering, stock could move huge after data comes out (up or down) but odds are good that it breaks to the upside given the technical pattern suggesting the smart...
It's been a while since the stock declined in what could be the final E leg down. Expect it to progress towards 900 now.
SGE published worse than expected numbers which triggered a 13% sell-off. It is likely the end of a corrective Wave 2. Time to start buying at this 580-ish levels to get on coming Wave 3 train.
All description on the chart. Please, don't forget to like and follow. Thank you.
Following a brutal sell off recently rolling a CEO step down, now could be the time for a long entry on SGE. Looking at an entry above Fridays high. Technical points: Engulfing bar on strong volume Rejection from lower Fib RSI 2 oversold May be good for a bounce. SL: 560 TP1: 608 TP2: 630
New and innovative product. Quell's proven technology is 5x more powerful on average than other over-the-counter pain relief devices. It is discreet and completely wearable to enable pain relief when your patients need it. Increased quarterly earnings growth. Low floater Resistance at at 3.00 range due to the preferred shares being exercisible at...
Possible short term breakout and buy in opportunity for Sage Therapeutics. This could be bull trap which would result in a short term loss of capital, but still a highly undervalued stock at its current price. Buy.